Intl Flavors & Fragrances Stock (NYSE: IFF)

Intl Flavors & Fragrances Stock (NYSE:IFF), Trade Ideas

Intl Flavors & Fragrances

International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.

Equities

News

Asset Sales

General

International Flavors &amp; Fragrances announces the sale of its Pharma Solutions unit to Roquette, a French plant-based ingredients company, for up to $2.85 billion. With an enterprise value multiple of approximately 13x, the sale marks a strategic move in IFF&#39;s portfolio optimization strategy. 

International Flavors &amp; Fragrances Sheds Pharma Solutions Unit For Up To $2.85B, Refocusing On Core Growth

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMPL

ATCH

AVGR

BFRI

BLCO

CPOP

EFOI

GBNH

GRMN

HCKT

IOVA

JANX

LIVN

MOTS

MTTR

PANW

PLAB

RAPT

SEDG

SEED

SISI

SNCR

SOGP

TDOC

THRM

TRTX

UCAR

VTYX

WTTR

Shares of  International Flavors &amp; Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Why International Flavors &amp; Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Earnings

Large Cap

Guidance

Dividends

IFF shares down premarket after reporting Q4 FY23 results with revenue of $2.703B, adjusted EPS of $0.72, and a dividend cut of 50%.

International Flavors &amp; Fragrances Shares Are Tumbling Premarket Today: Here&#39;s Why

International Flavors & Fragrances, Inc. Common Stock

International Flavors & Fragrances Inc

Infocom Corp

Barclays analyst Lauren Lieberman maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Underweight and raises the price target from $69 to $75.

Price Target

Analyst Ratings

Barclays Maintains Underweight on Intl Flavors & Fragrances, Raises Price Target to $75

Ratings for Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Intl Flavors &amp; Fragrances, revealing an average target of $89.93, a high estimate of $112.00, and a low estimate of $69.00. Witnessing a positive shift, the current average has risen by 8.91% from the previous average price target of $82.57.
<img src="https://www.benzinga.com/files/images/story/2024/1712775654_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Intl Flavors &amp; Fragrances. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$96.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$91.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$83.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$69.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$73.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Intl Flavors &amp; Fragrances. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Intl Flavors &amp; Fragrances compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Intl Flavors &amp; Fragrances's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Intl Flavors &amp; Fragrances's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IFF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Intl Flavors &amp; Fragrances analyst ratings.</a>
<h2>Get to Know Intl Flavors &amp; Fragrances Better</h2>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.
<h3>Intl Flavors &amp; Fragrances's Economic Impact: An Analysis</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Negative Revenue Trend: Examining Intl Flavors &amp; Fragrances's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -4.96% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Intl Flavors &amp; Fragrances's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -96.45%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Intl Flavors &amp; Fragrances's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -16.51%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -8.1%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Intl Flavors &amp; Fragrances's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.74.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Intl Flavors & Fragrances: Insights From 14 Financial Analysts

Citigroup analyst Patrick Cunningham upgrades Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) from Neutral to Buy and raises the price target from $81 to $100.

Upgrades

Citigroup Upgrades Intl Flavors & Fragrances to Buy, Raises Price Target to $100

Wells Fargo analyst Michael Sison maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Overweight and raises the price target from $90 to $100.

Wells Fargo Maintains Overweight on Intl Flavors & Fragrances, Raises Price Target to $100

CLZNF

IFF Completes Divestiture Of Cosmetics Ingredients Business To Clariant

Morgan Stanley analyst Lisa De Neve maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Overweight and raises the price target from $89 to $96.

Morgan Stanley Maintains Overweight on Intl Flavors & Fragrances, Raises Price Target to $96

Reported Earlier, IFF To Present Science-Driven Excipient Solutions At CPhI Japan 2024

Deutsche Bank analyst David Bellinger maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Buy and raises the price target from $90 to $100.

Deutsche Bank Maintains Buy on Intl Flavors & Fragrances, Raises Price Target to $100

Ratings for Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) were provided by 11 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $85.91, along with a high estimate of $112.00 and a low estimate of $69.00. This upward trend is apparent, with the current average reflecting a 6.91% increase from the previous average price target of $80.36.
<img src="https://www.benzinga.com/files/images/story/2024/1710939619_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Intl Flavors &amp; Fragrances's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$91.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$83.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$69.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Intl Flavors &amp; Fragrances. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Intl Flavors &amp; Fragrances compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Intl Flavors &amp; Fragrances's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Intl Flavors &amp; Fragrances's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IFF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Intl Flavors &amp; Fragrances analyst ratings.</a>
<h2>About Intl Flavors &amp; Fragrances</h2>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world. The firm also sells pharmaceutical ingredients such as excipients and time-release polymers.
<h3>Financial Insights: Intl Flavors &amp; Fragrances</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Decline in Revenue: Over the 3 months period, Intl Flavors &amp; Fragrances faced challenges, resulting in a decline of approximately -4.96% in revenue growth as of 31 December, 2023. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Intl Flavors &amp; Fragrances's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -96.45%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Intl Flavors &amp; Fragrances's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -16.51%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -8.1%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Intl Flavors &amp; Fragrances's debt-to-equity ratio is below the industry average. With a ratio of 0.74, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 11 Analyst Recommendations For Intl Flavors & Fragrances

Mizuho analyst John Roberts maintains Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Neutral and raises the price target from $83 to $91.

Mizuho Maintains Neutral on Intl Flavors & Fragrances, Raises Price Target to $91

International Flavors &amp; Fragrances Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) said it has entered into a definitive agreement to sell its Pharma Solutions business unit to French plant-based ingredients&nbsp;Roquette&nbsp;for an&nbsp;<a target="_blank" href="https://www.benzinga.com//node/37816032" rel="noreferrer noopener">enterprise value of up to $2.85 billion.</a>
The acquisition represents an enterprise value to EBITDA multiple of approximately 13x.
IFF&#8217;s Pharma Solutions business is a developer and manufacturer of pharmaceutical excipients. It includes Global Specialty Solutions business supporting industrial and methyl cellulosic food applications.&nbsp;
&#8220;An important next step in our portfolio optimization strategy, the sale of Pharma Solutions, along with other&nbsp;<a target="_blank" href="https://www.benzinga.com//node/37234587" rel="noreferrer noopener">recent actions such as our dividend rightsizing</a>, represents a significant step towards our commitment to reducing debt leverage to 3.0x or below,&#8221; said IFF CEO Erik Fyrwald.
&#8220;This also enables us to increase focus on the core drivers of long-term profitable growth and maximize value for our shareholders.&#8221;
Pharma Solutions operates 10 research and development and production sites globally, with about 1,100 employees, and generated approximately $1 billion revenue in 2023.&nbsp;
IFF held $735 million in cash and equivalents as of December 31, 2023. The transaction is expected to be closed in the first half of 2025.
Price Action: IFF shares are trading higher by 0.52% at $84.25 in premarket on the last check Tuesday.

International Flavors & Fragrances Sheds Pharma Solutions Unit For Up To $2.85B, Refocusing On Core Growth

IFF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to&nbsp;$2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x. IFF&#39;s Pharma Solutions business is a well-established developer and manufacturer of pharmaceutical excipients and includes its Global Specialty Solutions business supporting industrial and methyl cellulosic food applications. The Pharma Solutions business being sold to Roquette is primarily made up of businesses within IFF&#39;s existing Pharma Solutions division, with some adjustments to the perimeter of the transaction designed to align customers, businesses and the manufacturing footprint.

IFF Announces Sale of its Pharma Solutions Business to Roquette for an Enterprise Value of up to $2.85B

Argus Research analyst John Eade downgrades Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) from Buy to Hold.

Downgrades

Argus Research Downgrades Intl Flavors & Fragrances to Hold

Wolfe Research analyst Chris Parkinson initiates coverage on Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) with a Underperform rating.

Initiation

Wolfe Research Initiates Coverage On Intl Flavors & Fragrances with Underperform Rating

IFF Secures Approval Of SYNERXIA Yeasts For Biofuel Production In Argentina

Mizuho has decided to maintain its Neutral rating of Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) and raise its price target from $82.00 to $83.00.
Shares of Intl Flavors &amp; Fragrances are trading down 2.33% over the last 24 hours, at $78.61 per share.
A move to $83.00 would account for a 5.59% increase from the current share price.
<h3>About Intl Flavors &amp; Fragrances</h3>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world. The firm also sells pharmaceutical ingredients such as excipients and time-release polymers.
<h3>About Analyst Ratings</h3>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Mizuho Maintains Neutral Rating for Intl Flavors & Fragrances: Here's What You Need To Know

Throughout the last three months, 11 analysts have evaluated Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $85.73, a high estimate of $112.00, and a low estimate of $69.00. This upward trend is apparent, with the current average reflecting a 8.52% increase from the previous average price target of $79.00.
<img src="https://www.benzinga.com/files/images/story/2024/1708621241_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Intl Flavors &amp; Fragrances is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$85.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Christopher Parkinson</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$69.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$112.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$87.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>John Eade</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$85.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Intl Flavors &amp; Fragrances. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Intl Flavors &amp; Fragrances compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Intl Flavors &amp; Fragrances's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IFF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Intl Flavors &amp; Fragrances analyst ratings.</a>
<h2>About Intl Flavors &amp; Fragrances</h2>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world. The firm also sells pharmaceutical ingredients such as excipients and time-release polymers.
<h3>Financial Milestones: Intl Flavors &amp; Fragrances's Journey</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining Intl Flavors &amp; Fragrances's financials over 3 months reveals challenges. As of 31 December, 2023, the company experienced a decline of approximately -4.15% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -96.56%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Intl Flavors &amp; Fragrances's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -16.51%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Intl Flavors &amp; Fragrances's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -8.11%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Intl Flavors &amp; Fragrances's debt-to-equity ratio is below the industry average. With a ratio of 0.69, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings For Intl Flavors & Fragrances

Baird has decided to maintain its Outperform rating of Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) and raise its price target from $80.00 to $85.00.
Shares of Intl Flavors &amp; Fragrances are trading down 0.29% over the last 24 hours, at $76.56 per share.
A move to $85.00 would account for a 11.02% increase from the current share price.
<h3>About Intl Flavors &amp; Fragrances</h3>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world. The firm also sells pharmaceutical ingredients such as excipients and time-release polymers.
<h3>About Analyst Ratings</h3>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Baird Maintains Outperform Rating for Intl Flavors & Fragrances: Here's What You Need To Know

Shares of International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>) fell during Wednesday&rsquo;s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.
International Flavors &amp; Fragrances shares dipped 8.4% to $75.11 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) climbed 120.8% to $0.4351. Greenbrook TMS raised $2.5 million in debt financing.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) gained 84% to $2.8050. Emergent BioSolutions appointed Joseph Papa as President and CEO, effective Feb. 21, 2024.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) gained 77.2% to $5.30. Traders circulated unconfirmed analyst comments suggesting co might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1.</li>
<li>Sound Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sogp#NASDAQ">SOGP</a>) shares rose 63.1% to $4.60. Sound Group announced the launch of new AI-powered applications.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 59.4% to $1.04 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;</li>
<li>Origin Agritech Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seed#NASDAQ">SEED</a>) gained 34% to $3.11. Origin Agritech increased revenue by 77% year-over-year for the fiscal year ended Sep. 30, 2023.</li>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) gained 24% to $8.52.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) shares jumped 23.4% to $1.7050.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.2% to $135.56 following fourth-quarter results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained 6.6% to $110.42 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares tumbled 41% to $1.19.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dipped 33.4% to $1.53 after gaining around 56% on Tuesday.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) fell 32.2% to $8.30.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) dipped 30% to $0.0710 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.</li>
<li>MoneyHero Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mny#NASDAQ">MNY</a>) fell 28% to $2.2259.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 27.3% to $2.9350 after the company reported fourth-quarter financial results.</li>
<li>Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dipped 26.2% to $270.29 after the company issued third-quarter guidance below estimates.</li>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares fell 25.3% to $15.31 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>Unisys Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uis#NYSE">UIS</a>) fell 24.5% to $5.88 after the company reported quarterly financial results.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) fell 21.3% to $5.66 after jumping 171% on Tuesday.</li>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) fell 16.6% to $11.73 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 15.7% to $71.20 after the company reported mixed fourth-quarter financial results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares fell 15.4% to $2.1450 after the company posted weak quarterly sales and issued downbeat forecast.</li>
<li>Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) fell 14.8% to $212.15.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) declined 14.3% to $41.95 after the company issued weak guidance.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares fell 14.3% to $4.57 after surging 83% on Tuesday.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) fell 13% to $27.17 after the company reported first-quarter financial results below estimates.</li>
<li>Workiva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wk#NYSE">WK</a>) fell 12.3% to $82.55 following quarterly results.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) fell 11.4% to $0.5582.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) shares fell 6.1% to $1.0794. Biofrontera shares jumped 53% on Tuesday after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) shares declined 5.4% to $61.01 after the company reported fourth-quarter financial results and issued guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser</a>

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

WIIM

IFF shares are trading lower after the company reported mixed Q4 financial results and reduced its expected quarterly dividend approximately 50% to $0.40 per share.

International Flavors and Fragrances Inc (IFF) stock is higher by 4.13% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator. International Flavors and Fragrances Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IFF!See Full IFF Rep

Do Traders Think International Flavors & Fragrances Inc (IFF) Can Keep Climbing Monday?

There's a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Martin Marietta Materials (MLM – Research Report) and...

Analysts Offer Insights on Materials Companies: Martin Marietta Materials (MLM) and International Flavors & Fragrances (IFF)

IFF upgraded at Citigroup on rising profit margin

Linde downgraded at Citigroup on valuation

New additions to Goldman's High Operating Leverage list

Wells Fargo analyst Michael Sison maintained a Buy rating on International Flavors & Fragrances (IFF – Research Report) yesterday and set a price t...

International Flavors & Fragrances (IFF): New Buy Recommendation for This Basic Materials Giant

In a report released today, Lauren Lieberman from Barclays maintained a Sell rating on International Flavors & Fragrances (IFF – Research Report), ...

International Flavors & Fragrances (IFF): New Sell Recommendation for This Basic Materials Giant

U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map

Baird's top picks in the Packaging and Coaters subindustry

Jefferies urges deeper dive into mid-caps, picks 12 ideas including GTA-publisher Take-Two

ADBE

ADSK

AKAM

ARGX

AXON

BIIB

BMYMP

CHRW

CMCSA

CRBG

CTVA

ETSY

FCFS

FSLR

GILD

GLBE

KVUE

MDLZ

MKTX

PARA

PODD

QRVO

SBUX

TRMB

UBER

VEEV

VRSN

VTRS

ZBRA

Press Releases

IFF Reports Fourth Quarter and Full Year 2023 Results

IFF Receives Approval of SYNERXIA® Yeasts for Biofuel Production in Argentina

IFF Named Top Company in the U.S. for Gender Equality in 2024

IFF Announces Grant of Employment Inducement Awards

IFF Launches Advertising Campaign Celebrating The Art Of Perfumery

IFF Announces Sale of its Pharma Solutions Business to Roquette

IFF Names Ana Paula Mendonça President, Scent

IFF Brings Science-Backed Excipients to Asia Pharmaceutical Industry at CPhI Japan 2024